-+ 0.00%
-+ 0.00%
-+ 0.00%

Cantor Fitzgerald Initiates Coverage On Electra Therapeutics with Overweight Rating

Benzinga·10/13/2026 10:56:02
Cantor Fitzgerald analyst Eric Schmidt initiates coverage on Electra Therapeutics (NASDAQ:ETRA) with a Overweight rating.